- Sera Prognostics (SERA, Financial) to release Q1 2025 financial results on May 7, 2025.
- Conference call and webcast scheduled at 5:00 p.m. Eastern Time.
- Webcast available live and archived on the company's website for one year.
Sera Prognostics, Inc. (SERA), a leader in maternal and neonatal health diagnostics, will announce its financial results for the first quarter of fiscal year 2025 on May 7, 2025, following the close of the market. The company's conference call and live webcast will take place at 5:00 p.m. Eastern Time to discuss the operational highlights and financial outcomes.
Domestic participants can join the conference by dialing (800) 836-8184, while international callers should use (646) 357-8785. Additionally, the live webcast can be accessed via the Investors page on Sera's website, where it will also be archived for a year.
As The Pregnancy Company, Sera Prognostics is committed to enhancing the health of mothers and babies, particularly through their precision medicine PreTRM® Test, which helps predict the risk of spontaneous preterm birth. This early detection allows healthcare providers to make informed, proactive decisions to manage pregnancies at higher risk effectively.
For more information, visit Sera Prognostics' official website at www.sera.com.
